Additionally, people with certain medical conditions, such as heart disease, diabetes, or chronic fatigue syndrome, may benefit from intravenous L-Carnitine injections
Know the risks, including those that aren't on the label Kessler worries about people taking the drugs going too far in the other direction from overeating to malnutrition
Assessment of gastrointestinal symptoms focuses on nausea, vomiting, early satiety, bloating, and abdominal pain, which correlate with increased gastric retention risk [32]
Robinson JK
The evidence suggests yes, but formulation also matters significantly
Sodium dependent cationic transporter (OCTN2) [4] is the primary known transporter responsible both for transport of carnitine to other tissues and reabsorption in kidney